drugset / Trial / NCT00452543
Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
Phase 4
Completed
23 enrolled
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a study about treatment for people who suffer from both major depression and alcohol abuse or dependence. The study will examine whether the addition of acamprosate to escitalopram and behavioral interventions will improve outcomes for this population.
Timeline
- Start
- 2007-03
- Primary completion
- 2010-05
- Completion
- 2010-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acamprosate | Small molecule | 333 mg | Oral |
| Background | Escitalopram | Small molecule | 30 mg | Oral |